TSNDF

TerrAscend Corp.

$0.65

-0.01 (-0.76%)

Mkt Cap 242.48M

Volume 70,952

52W Range 0.227-1.45

Sector Healthcare

Beta 2.04

EPS (TTM) -0.17

P/E Ratio -2.55

Revenue (TTM) 255.10M

Rev Growth (5Y) +5.6%

EPS Growth (5Y) N/A

AlphaVal · Fair Value

$0.00

Overvalued · Mild

0.0% below fair value

Company Description

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, GAGE Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, Cookies, and Lemonnade. The company also operates retail dispensaries under the Apothecarium, TerrAscend, Pinnacle Emporium, GAGE Cannabis, and State Flower brand names. It serves medical patients and adult-use consumers in North America. The company was incorporated in 2017 and is headquartered in King Of Prussia, Pennsylvania.

Track Record

Showing latest 4 periods • Swipe for more

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	260.56M	441.03M	317.33M	247.83M	194.21M	198.32M	84.87M	6.83M	0	0	0	0
Net Income	(86.23M)	(80.23M)	(91.10M)	(303.96M)	12.63M	(139.20M)	(215.79M)	(22.03M)	(6.81M)	(867,181)	(760,529)	(386,651)
EPS	-0.29	-0.28	-0.33	-1.67	0.07	-0.83	-2.17	-0.21	-0.18	-0.03	-0.13	-0.13
Free Cash Flow	13.31M	28.59M	18.04M	(87.88M)	(88.86M)	(28.10M)	(92.98M)	(37.87M)	(18.53M)	(426,908)	N/A	N/A
FCF / Share	0.04	0.10	0.06	-0.36	-0.49	-0.19	-0.93	-0.42	-0.49	-0.01	N/A	N/A
Operating CF	22.07M	37.95M	27.47M	(33.34M)	(38.45M)	33.01M	(47.91M)	(25.09M)	(4.15M)	(422,640)	N/A	N/A
Total Assets	557.38M	607.23M	666.52M	950.62M	581.93M	545.54M	460.77M	88.98M	69.06M	3.87M	N/A	N/A
Total Debt	256.49M	246.18M	255.70M	234.82M	211.44M	207.05M	103.97M	12.62M	0	0	N/A	N/A
Cash & Equiv	37.41M	26.38M	22.24M	36.26M	100.60M	75.41M	11.90M	21.77M	51.82M	3.33M	N/A	N/A
Book Value	97.48M	176.82M	319.76M	431.95M	223.59M	1.19M	66.68M	56.47M	67.37M	2.08M	N/A	N/A
Return on Equity	-0.88	-0.45	-0.28	-0.70	0.06	-117.27	-3.24	-0.39	-0.10	-0.42	N/A	N/A

Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Revenue	65.54M	59.45M	65.10M	65.01M	71.00M	74.35M	74.17M	77.52M	80.63M	86.57M	89.24M	72.12M
Net Income	(8.93M)	2.49M	(25.76M)	(49.38M)	(13.57M)	(31.85M)	(23.15M)	(8.18M)	(17.05M)	(44.14M)	(10.83M)	(15.62M)
EPS	-0.03	0.01	-0.12	-0.03	-0.05	-0.11	-0.08	-0.03	-0.06	-0.15	-0.04	-0.05
Free Cash Flow	7.56M	6.40M	613,276	625,000	5.55M	(26.73M)	1.47M	11.33M	13.93M	10.93M	7.21M	(5.01M)
FCF / Share	0.02	0.02	0.00	0.00	0.02	-0.09	0.01	0.04	0.05	0.04	0.03	-0.02
Operating CF	8.41M	8.14M	3.71M	2.82M	8.00M	(32.82M)	1.82M	13.13M	13.25M	9.42M	8.93M	(1.98M)
Total Assets	549.10M	557.38M	555.26M	572.01M	600.73M	607.23M	656.93M	660.24M	655.54M	666.52M	993.27M	955.05M
Total Debt	254.68M	256.49M	254.62M	42.52M	245.82M	246.18M	246.24M	243.22M	248.00M	255.70M	262.09M	261.92M
Cash & Equiv	39.24M	37.41M	36.52M	26.67M	29.25M	26.38M	26.64M	27.38M	22.66M	22.24M	25.41M	42.37M
Book Value	87.92M	97.48M	93.87M	118.39M	164.69M	176.82M	206.06M	224.66M	230.62M	242.50M	284.20M	293.63M
Return on Equity	-0.10	0.03	-0.27	-0.42	-0.08	-0.18	-0.11	-0.04	-0.07	-0.18	-0.04	-0.05